Literature DB >> 10748948

Differential diagnosis of the patient with unexplained flushing/anaphylaxis.

D D Metcalfe1.   

Abstract

In unusual cases of flushing and anaphylaxis, and after the elimination of the more obvious causes of anaphylaxis or those that may be evaluated by readily available techniques, it is possible to confront a limited and difficult differential diagnosis, which includes idiopathic flushing, anaphylaxis, and neoplastic syndromes associated with mastocytosis and carcinoid tumor. Interestingly, there are rather few features that distinguish one of these possibilities from another. However, the presence of allergic signs and symptoms tend to favor the diagnosis of recurrent idiopathic anaphylaxis; and right-sided valvular heart disease, the presence of excessive 5-HIAA in the urine, and a response to somatostatin favor the diagnosis of carcinoid syndrome. The distinguishing features of mastocytosis include the presence of characteristic skin lesions and diagnostic histopathologic findings on bone marrow biopsy. Counts of absolute mast cell numbers in the skin are less helpful. Following such guidelines, it is often possible to focus on the most likely diagnosis, be it idiopathic anaphylaxis, benign cutaneous flushing, mastocytosis, or carcinoid tumor.

Entities:  

Mesh:

Year:  2000        PMID: 10748948     DOI: 10.2500/108854100778249006

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  10 in total

1.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

Review 2.  Mast Cell Activation Syndrome.

Authors:  Marianne Frieri
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 3.  Mast cell activation syndrome: a review.

Authors:  Marianne Frieri; Reenal Patel; Jocelyn Celestin
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 4.  Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Cem Akin
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

Review 5.  Flushing in (neuro)endocrinology.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 6.  Immunology and clinical manifestations of non-clonal mast cell activation syndrome.

Authors:  Juan-Carlos Cardet; Mariana C Castells; Matthew J Hamilton
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

7.  Idiopathic Flushing with Dysesthesia: Treatment with the 585nm Pulsed Dye Laser.

Authors:  Joshua P Fogelman; Mary L Stevenson; Robin Ashinoff; Nicholas A Soter
Journal:  J Clin Aesthet Dermatol       Date:  2015-08

8.  Activation of the ileal neuroendocrine tumor cell line P-STS by acetylcholine is amplified by histamine: role of H3R and H4R.

Authors:  Beatrix Pfanzagl; Diana Mechtcheriakova; Anastasia Meshcheryakova; Stephan W Aberle; Roswitha Pfragner; Erika Jensen-Jarolim
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 9.  Management Strategies Of Idiopathic Anaphylaxis In The Emergency Room: Current Perspectives.

Authors:  Michelle Le; Sofianne Gabrielli; Sarah De Schryver; Moshe Ben-Shoshan
Journal:  Open Access Emerg Med       Date:  2019-11-01

10.  Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor.

Authors:  Corey A Carter; Aiste Degesys; Bryan Oronsky; Jan Scicinski; Scott Z Caroen; Arnold L Oronsky; Tony Reid; Pedro Cabrales; Joe Roswarski
Journal:  Case Rep Oncol       Date:  2015-10-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.